News
Diagnostics play a vital role in the fight against infectious outbreaks, but these tools need to be developed early enough to enable a rapid and effective response. This is where preparedness is essential.

Swipe to discover more
-
Third-Quarter 2023 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2023. Consolidated sales amounted to €2,668 million for the first nine months of 2023. -
Diagnosis, an essential link for preventive medicine
While calls for more prevention in public health strategies are increasing, in vitro diagnosis appears to be a major tool at all stages. Explanation, with Isabelle Tongio, Director of Public and Government Affairs at bioMérieux. -
A Stronger Business Relationship to Enhance bioMérieux’s BIOFIRE® SPOTFIRE® Presence in the US Outpatient Diagnostic Market
bioMérieux has strengthened its relationship with McKesson Medical-Surgical, a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere.
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19